Variables | OR | 95% CI | P |
---|---|---|---|
Model A | |||
 Male gender | 0.48 | 0.15–1.52 | 0.21 |
 Chronic kidney disease | 1.63 | 0.34–7.91 | 0.541 |
 Malignant tumor | 6.25 | 0.59–66.76 | 0.129 |
 History of cerebral infarction | 3.63 | 1.03–12.84 | 0.046 |
 NIHSS on admission | 1.08 | 0.98–1.18 | 0.111 |
 eGFR | 0.97 | 0.94–1.00 | 0.087 |
 BNP | 1 | 1.00–1.01 | 0.403 |
 Lesion size > 30 mm in diameter | 2.13 | 0.75–6.05 | 0.155 |
 RLS | 4.62 | 1.46–14.61 | 0.009 |
Model B | |||
 Male gender | 0.49 | 0.15–1.61 | 0.242 |
 Chronic kidney disease | 1.66 | 0.34–8.19 | 0.536 |
 Malignant tumor | 6.21 | 0.56–69.27 | 0.138 |
 History of cerebral infarction | 3.55 | 1–12.57 | 0.05 |
 NIHSS on admission | 1.07 | 0.98–1.18 | 0.153 |
 eGFR | 0.97 | 0.94–1.01 | 0.093 |
 BNP | 1.00 | 1.00–1.01 | 0.348 |
 Lesion size > 30 mm in diameter | 2.04 | 0.71–5.91 | 0.188 |
 RLS | |||
  Without DVT | 3.9 | 1.20–12.70 | 0.024 |
  With DVT | 13.94 | 1.77–109.99 | 0.012 |